Funding for this research was provided by:
Science and Technology Innovation Plan Of Shanghai Science and Technology Commission (21YF1406300)
Natural Science Foundation of Shanghai Municipality (22ZR1411400)
Youth Foundation of Zhongshan hospital Fudan University (2021ZSQNN61)
Article History
Received: 14 March 2025
Revised: 11 April 2025
Accepted: 14 April 2025
First Online: 24 April 2025
Declarations
:
: The study was approved by the Ethics Committee of Fudan University Zhong Hospital (B2017 - 031R) and complied with the principles of the Helsinki Accord. This is a retrospective study, and all patients have given their consent for the collection and utilization of their clinical information for this research.
: Peng Liu is one of the editors of Clinical Cancer Bulletin. Other authors declare no conflict of interest.